Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2020 / Apr / A Letter From Lockdown
Infectious Disease Profession Professional Development

A Letter From Lockdown

With a pandemic at hand, laboratory medicine professionals must no longer be hidden heroes

By Michael Schubert 04/15/2020 1 min read

Share

As a child in the Canadian wilderness, I went survival camping every year in the Rockies – in one of the highest-density bear populations in North America. The park rangers taught us how to tell the difference between black bears and grizzlies (far more dangerous): climb a tree. If the bear climbs up after you, it’s a black bear. If it stays at the bottom and shakes you down, it’s a grizzly.

But there’s no such risk stratifier for unprecedented events like the COVID-19 pandemic that’s currently gripping most nations of the world. How could we be certain of the risk posed by a virus like SARS-CoV-2 without adequate tools for testing and tracking? How could we count the number who had been infected and survived if we didn’t have retroactive antibody tests? And – now that these tools are beginning to gain approval and reach end users – how can we be sure of what we think we know about COVID-19 if we’re not able to test everyone with symptoms of the disease?

The headlines are full of conversations about capacity. How many ventilators do we have? How many hospital beds are available? At what point must we begin to decide which patients warrant hospitalization, medication, ventilation? Less commonly discussed is the laboratory’s capacity to take on testing for up to 60 percent of the population (1) – and that’s on top of its regular workload. Laboratory staffing shortages have been reported for years and burnout levels were high long before COVID-19 was on the horizon. Now, pathologists and laboratory medicine professionals are being asked to deliver long hours in risky circumstances for a patient population that may never be aware of the lab’s role in their care – and in helping to stem the tide of a pandemic that has claimed tens of thousands of lives.

The cynics among you may ask, “How is that different to any other time?” But now, more than ever, the lab is proving its importance not just to current patients, but to all seven and a half billion people on Earth. And now, more than ever, it’s our job to listen to the lab’s results and recommendations, and to take them seriously. That’s why I’m writing this editorial from lockdown – where I’ll be staying until the laboratory medicine and public health professionals I trust tell me it’s safe to leave.

Newsletters

Receive the latest analytical scientist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. J Allen, M Lipsitch, “6 things to know if you’re living with someone who has coronavirus, or think you might be” (2020). Available at: https://bit.ly/33MN2vT.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Analytical Science

Dive deeper into the analytical science. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Viral Frontier
Infectious Disease
The Viral Frontier

January 23, 2024

1 min read

The latest on the UK COVID-19 inquiry

What’s New in Infectious Disease? (December 2021)
Infectious Disease
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Infectious Disease
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

Pneumocystis Mysteries
Infectious Disease
Pneumocystis Mysteries

January 21, 2022

1 min read

What is the correct name for this pneumonia-causing pathogen?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.